reference/556660

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/556660

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	163
issn	0304-3835
pageRange	155-163
publicationName	Cancer Letters
startingPage	155
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_23fe99b45a2dbfc8f410e556b4033b4c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0352fa9dbf5677f98c9a97bb83d9d515 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2535bdab3cb1db992732eb7ffd9461e7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Chen J, Li L, Yang Z, Luo J, Yeh S, Chang C. Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression. Cancer Lett. 2017 Nov 01;408():155–63. doi: 10.1016/j.canlet.2017.08.014. PMID: 28826721.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc2276323be50228187d9375a7bd9d17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8510-3516 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62db8d75a40c60f4e985d0af85789d40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1eacdd19fafc590b72a800ffc3b9a30 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f808d5a739800aa037da7d2b93d85962 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f47878a02144fe5b69f8be17de129ae5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc90492a8d7ead1c363434f536559796
date	2017-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/j.canlet.2017.08.014 https://pubmed.ncbi.nlm.nih.gov/28826721
isPartOf	https://portal.issn.org/resource/ISSN/0304-3835 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2780
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression
discusses	http://id.nlm.nih.gov/mesh/M0001103 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0278140 http://id.nlm.nih.gov/mesh/M0018556 http://id.nlm.nih.gov/mesh/M0577955 http://id.nlm.nih.gov/mesh/M0333630 http://id.nlm.nih.gov/mesh/M0016576 http://id.nlm.nih.gov/mesh/M0014878
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D064129Q000556 http://id.nlm.nih.gov/mesh/D010669Q000031 http://id.nlm.nih.gov/mesh/D000726Q000494 http://id.nlm.nih.gov/mesh/D036081Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D064129Q000188 http://id.nlm.nih.gov/mesh/D009570 http://id.nlm.nih.gov/mesh/D011944Q000737 http://id.nlm.nih.gov/mesh/D064129Q000378 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D011944Q000378 http://id.nlm.nih.gov/mesh/D015972Q000187 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D009362 http://id.nlm.nih.gov/mesh/D002465Q000187 http://id.nlm.nih.gov/mesh/D009361 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D036081Q000235 http://id.nlm.nih.gov/mesh/D010669Q000494
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b3bd3d37efbf0647a514f49f149b95d3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8b5b5bdbd09585ee176b45bc35e769ad http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9e12d6abd3e6102383e948ea50ba840b http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15951529 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8515 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07edfd5399a4297179b0eb6e7ec0142a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2051

Total number of triples: 69.